-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Cost of Revenue history and growth rate from 2010 to 2023.
- Elite Pharmaceuticals Inc /Nv/ Cost of Revenue for the quarter ending June 30, 2024 was $10.3M, a 144% increase year-over-year.
- Elite Pharmaceuticals Inc /Nv/ Cost of Revenue for the twelve months ending June 30, 2024 was $36.4M, a 101% increase year-over-year.
- Elite Pharmaceuticals Inc /Nv/ annual Cost of Revenue for 2023 was $30.3M, a 72.4% increase from 2022.
- Elite Pharmaceuticals Inc /Nv/ annual Cost of Revenue for 2022 was $17.6M, a 0.54% increase from 2021.
- Elite Pharmaceuticals Inc /Nv/ annual Cost of Revenue for 2021 was $17.5M, a 29.3% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)